Sodium butyrate (NaB) and AB38b are two synthetic compounds evaluated in diabetic mouse models that could be effective agents in improving DKD via the NRF2/KEAP1/ARE pathway [183,184]. The gene discussed is NFE2L2; the disease is diabetic kidney disease.